ADN Mainnet is a blockchain-based technology designed to secure ICO investments. Going beyond decentralization, we are pioneers of a built-in investor-oriented mechanism to ensure security and transparency to our investors. ADN aims to transcend into the future of blockchain and ICO with continuous development and innovation. Aiming to provide a tangible solution to existing problems within the industry, we developed a blockchain with high-throughput, high scalability, and high availability for Decentralized Applications (DApps) in the ADN ecosystem. Combining the benefits initially proposed by its cryptocurrency predecessors such as Bitcoin, Ethereum, EOS and TRON, the ADN protocol becomes a high-performance blockchain platform. Integrating the Delegated Proof-of-Stake (dPoS) consensus and ADN Virtual Machine (AVM), it primarily focuses on smart contracts, consensus, and ICO wallet.
SHIVOM is building the largest genomic and health data hub around the globe by combining blockchain, genomic DNA sequencing, artificial intelligence and cryptography to power secure and personalized medicine. Everybody will be able to get their genome sequenced and securely stored, and our ecosystem will offer an open web-marketplace for providers to add their apps and services alongside advanced data analytics. The SHIVOM platform works on principles of collaboration and integrity, allowing people to own, manage and monetize their genomics and health data. As we build this global healthcare ecosystem, we will reach even underserved and low-income countries where such services have not been previously available. Our solution will create shared value for individuals, not-for-profit organizations, governments, and for-profit entities alike. The platform is truly pioneering in the way it utilizes blockchain technology, to protect, secure and monetize the donor’s DNA data to drive precision medicine and healthcare forward.